Capital Flow Monitor · Sponsors · CIK 1861657
Canton Strategic Holdings, Inc.
34 SHREWSBURY AVE., RED BANK, NJ, 07701 · (732) 889-3111
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$2.5M
Sold
$2.5M
% sold
100.0%
Investors
30
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | D | 506(b) | $1.2M | $1.2M | 100.0% | 6 | EDGAR ↗ |
| 2026-04-15 | D | 506(b) | $1.7M | $1.7M | 100.0% | 13 | EDGAR ↗ |
| 2025-07-07 | D ·current | 506(b) | $2.5M | $2.5M | 100.0% | 30 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Sireesh Appajosyula — Executive Officer / Director, Red Bank, NJ
1 other raise
- Hepion Pharmaceuticals, Inc. $3.1M of $3.1M · 100.0%
-
Vincent LoPriore — Executive Officer / Director, Red Bank, NJ
1 other raise
- Hepion Pharmaceuticals, Inc. $3.1M of $3.1M · 100.0%
- Sanam Parikh — Director, Red Bank, NJ
- Clay Kahler — Director, Red Bank, NJ
-
Gary Stetz — Director, Red Bank, NJ
1 other raise
- Hepion Pharmaceuticals, Inc. $3.1M of $3.1M · 100.0%
- James Gordon Liddy — Director, Red Bank, NJ
Placement agents
- President Street Global Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.